Anbio Biotechnology Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 26.74 K | $366.55 K | 3.78% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 13.42 K | $183.97 K | 100.00% | 0.03% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 11.80 K | $161.78 K | 13.46% | 0.03% |
| MARSHALL WACE, LLP | 08/13/2026 | 11.50 K | $157.69 K | 100.00% | 0.03% |
| MORGAN STANLEY | 08/13/2026 | 7.23 K | $99.14 K | -1.46% | 0.02% |
| UBS GROUP AG | 08/13/2026 | 828 | $11.35 K | -86.94% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 07/24/2026 | 187 | $2.56 K | -29.70% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 77 | $1.06 K | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 53 | $718 | 100.00% | 0.00% |
| BARE FINANCIAL SERVICES, INC | 07/27/2026 | 15 | $206 | 0.00% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 08/14/2026 | 5 | $69 | 100.00% | 0.00% |
| SILVER GROVE FINANCIAL GROUP, INC. | 08/13/2026 | 4 | $55 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| RONALD BLUE TRUST, INC. | 07/21/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Anbio Biotechnology institutional Ownership - FAQ's
During the previous two years, 14 institutional investors and hedge funds held shares of Anbio Biotechnology. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 26,736
BANK OF AMERICA CORP /DE/: 13,419
BNP PARIBAS ARBITRAGE, SNC: 11,800
MARSHALL WACE, LLP: 11,502
MORGAN STANLEY: 7,231
UBS Group AG: 828
0.16% of Anbio Biotechnology stock is owned by institutional investors.
Institutional investors have bought a total of 71.86 K shares in the last 24 months. This purchase volume represents approximately $1.60 M in transactions.